These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7561849)

  • 1. Sphingolipid biosynthesis is necessary for dendrite growth and survival of cerebellar Purkinje cells in culture.
    Furuya S; Ono K; Hirabayashi Y
    J Neurochem; 1995 Oct; 65(4):1551-61. PubMed ID: 7561849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ.
    Merrill AH; van Echten G; Wang E; Sandhoff K
    J Biol Chem; 1993 Dec; 268(36):27299-306. PubMed ID: 8262970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceramide and its interconvertible metabolite sphingosine function as indispensable lipid factors involved in survival and dendritic differentiation of cerebellar Purkinje cells.
    Furuya S; Mitoma J; Makino A; Hirabayashi Y
    J Neurochem; 1998 Jul; 71(1):366-77. PubMed ID: 9648886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of sphingolipid synthesis affects axonal outgrowth in cultured hippocampal neurons.
    Harel R; Futerman AH
    J Biol Chem; 1993 Jul; 268(19):14476-81. PubMed ID: 8314804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fumonisin inhibition of de novo sphingolipid biosynthesis and cytotoxicity are correlated in LLC-PK1 cells.
    Yoo HS; Norred WP; Wang E; Merrill AH; Riley RT
    Toxicol Appl Pharmacol; 1992 May; 114(1):9-15. PubMed ID: 1585377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of sphingolipid biosynthesis by fumonisins. Implications for diseases associated with Fusarium moniliforme.
    Wang E; Norred WP; Bacon CW; Riley RT; Merrill AH
    J Biol Chem; 1991 Aug; 266(22):14486-90. PubMed ID: 1860857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingolipid biosynthesis de novo by rat hepatocytes in culture. Ceramide and sphingomyelin are associated with, but not required for, very low density lipoprotein secretion.
    Merrill AH; Lingrell S; Wang E; Nikolova-Karakashian M; Vales TR; Vance DE
    J Biol Chem; 1995 Jun; 270(23):13834-41. PubMed ID: 7775441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of sphingolipid synthesis, but not degradation, alters the rate of dendrite growth in cultured hippocampal neurons.
    Schwarz A; Futerman AH
    Brain Res Dev Brain Res; 1998 Jun; 108(1-2):125-30. PubMed ID: 9693790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of sphingolipid synthesis modulate interferon (IFN)-gamma-induced intercellular adhesion molecule (ICAM)-1 and human leukocyte antigen (HLA)-DR expression on cultured normal human keratinocytes: possible involvement of ceramide in biologic action of IFN-gamma.
    Wakita H; Nishimura K; Tokura Y; Furukawa F; Takigawa M
    J Invest Dermatol; 1996 Sep; 107(3):336-42. PubMed ID: 8751967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of lipid biosynthesis in Saccharomyces cerevisiae by fumonisin B1.
    Wu WI; McDonough VM; Nickels JT; Ko J; Fischl AS; Vales TR; Merrill AH; Carman GM
    J Biol Chem; 1995 Jun; 270(22):13171-8. PubMed ID: 7768913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated sphingoid bases and complex sphingolipid depletion as contributing factors in fumonisin-induced cytotoxicity.
    Yoo HS; Norred WP; Showker J; Riley RT
    Toxicol Appl Pharmacol; 1996 Jun; 138(2):211-8. PubMed ID: 8658522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fumonisin toxicity and sphingolipid biosynthesis.
    Merrill AH; Wang E; Vales TR; Smith ER; Schroeder JJ; Menaldino DS; Alexander C; Crane HM; Xia J; Liotta DC; Meredith FI; Riley RT
    Adv Exp Med Biol; 1996; 392():297-306. PubMed ID: 8850625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A regulatory role for sphingolipids in neuronal growth. Inhibition of sphingolipid synthesis and degradation have opposite effects on axonal branching.
    Schwarz A; Rapaport E; Hirschberg K; Futerman AH
    J Biol Chem; 1995 May; 270(18):10990-8. PubMed ID: 7738041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid-metabolizing systems in mouse liver.
    He Q; Suzuki H; Sharma N; Sharma RP
    Toxicol Sci; 2006 Dec; 94(2):388-97. PubMed ID: 16960033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered de novo sphingolipid biosynthesis is involved in the serum deprivation-induced cell death in LLC-PK1 cells.
    Yu MU; Yoo JM; Lee YS; Lee YM; Hong JT; Oh KW; Song S; Yun YP; Yoo HS; Oh S
    J Toxicol Environ Health A; 2004 Dec; 67(23-24):2085-94. PubMed ID: 15513905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of fumonisin B1 on developing chick embryos: correlation between de novo sphingolipid biosynthesis and gross morphological changes.
    Zacharias C; van Echten-Deckert G; Wang E; Merrill AH; Sandhoff K
    Glycoconj J; 1996 Apr; 13(2):167-75. PubMed ID: 8737241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosynthesis of sphingolipids: dihydroceramide and not sphinganine is desaturated by cultured cells.
    Rother J; van Echten G; Schwarzmann G; Sandhoff K
    Biochem Biophys Res Commun; 1992 Nov; 189(1):14-20. PubMed ID: 1449467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of fungal species for fumonisin production and fumonisin-like disruption of sphingolipid biosynthesis.
    Norred WP; Bacon CW; Riley RT; Voss KA; Meredith FI
    Mycopathologia; 1999; 146(2):91-8. PubMed ID: 10822508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fumonisin B1 induces apoptosis in cultured human keratinocytes through sphinganine accumulation and ceramide depletion.
    Tolleson WH; Couch LH; Melchior WB; Jenkins GR; Muskhelishvili M; Muskhelishvili L; McGarrity LJ; Domon O; Morris SM; Howard PC
    Int J Oncol; 1999 May; 14(5):833-43. PubMed ID: 10200332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumonisins.
    Riley RT; Wang E; Schroeder JJ; Smith ER; Plattner RD; Abbas H; Yoo HS; Merrill AH
    Nat Toxins; 1996; 4(1):3-15. PubMed ID: 8680751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.